Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Thursday, December 3, 2020

Dostarlimab in the treatment of recurrent or primary advanced endometrial cancer

Cancer shared this article with you from Inoreader
Future Oncology, Ahead of Print.
View on the web

No comments:

Post a Comment